Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
84,777,416
-
Share change
-
-2,716,107
-
Total reported value
-
$3,856,100,900
-
Put/Call ratio
-
16%
-
Price per share
-
$45.45
-
Number of holders
-
225
-
Value change
-
-$118,084,536
-
Number of buys
-
105
-
Number of sells
-
115
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q2 2016
As of 30 Jun 2016,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,777,416 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BB BIOTECH AG, PERCEPTIVE ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, and ORBIMED ADVISORS LLC.
This page lists
225
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.